Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

Fulcrum Therapeutics Inc. (Nasdaq: FULC)

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum's therapies are based on 3 modulating gene regulation via control of genetic on and off switches of disease genes. Fulcrum was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. *


Period Start 2016-07-01 established
Product Industry BIOTECH
Person Person Gould, Robert J. (Fulcrum Therapeutics 201607– CEO before Epizyme + Broad Institute + Merck Research Labs)
Region Region Cambridge, MA
  Country United States (USA)
  Street 26 Landsdowne Street
  City 02139 Cambridge, MA
  Tel +1-617-651-8851
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: 
Record changed: 2019-09-08


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Fulcrum Therapeutics Inc. (Nasdaq: FULC)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2021 NYC B Preview Download 650x300px

» top